focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

16 Aug 2010 08:50

RNS Number : 1119R
Phorm Inc
16 August 2010
 



16th August 2010

Phorm, Inc. ('Phorm' or 'the Company')

 

Phorm Announces Board Changes

 

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, announces the following changes to the Company's Board:

 

Mark Schneider is appointed to the Board as a Non-Executive Director. Mark was co-founder of leading European cable group UPC, which was subsequently acquired by Liberty Global in 2005. Mark has served on public and private company boards of companies operating in over 20 countries around the world, including United Artist Entertainment, UIH, UnitedGlobalCom, UPC, SBS Broadcasting and Blockbuster Video. With his background in international cable and telecommunications, Mark brings strong operating knowledge and an extensive network of contacts to the Board.

 

Kip Meek will step down from the Board with immediate effect. This follows Kip's previously announced appointment as Chairman of Project Canvas.

 

Kent Ertugrul, CEO of Phorm, commented, "I would like to thank Kip for his valuable insights and advice, which have contributed to the progress made by the Company since his appointment. We are sorry to see Kip go, but recognise that he needs to focus his energies on Project Canvas. We wish him well.

 

Meanwhile, we welcome Mark Schneider to the Board. He brings with him an in-depth understanding of media and telecommunications, has operated in multiple markets globally, and remains one of the pioneers of the international cable industry. We look forward to working with Mark to deliver on the substantial promise of our Company."

 

Save as set out in the Appendix, there are no further details in relation to the above appointment which require disclosure under paragraph (g) of Schedule 2 to the AIM rules.

 

Enquiries:

 

Phorm, Inc

Sarah Simon: +44 20 7297 2433 (analysts and investors)

Alex Laity: +44 20 7297 2710 (press)

 

Citigate Dewe Rogerson +44 20 7638 9571

Simon Rigby

Justin Griffiths

 

Canaccord Genuity Limited +44 20 7050 6500

(Nominated Adviser)

Mark Williams

Andrew Chubb

 

 

Appendix:

 

Information provided in accordance with paragraph g of Schedule 2 to the AIM rules:

 

1. Details of full name, age, previous names:

 

Full Name: Mark Lyle Schneider

Age: 55

 

2. Names of all companies and partnerships of which the director has been a director or partner at any time in the previous five years, indicating whether or not the director is still a director or partner

 

General Media Services Limited - present

Schneider Media Africa Limited - present

Africa Telecommunications Media and Technology Fund 1 LLC - present

Big Sleep Hotels - present

Ricall Limited - present

Shorts Entertainment Limited - present

 

In addition, Mr Schneider has, in relation to this appointment as a Non-Executive Director, today been granted options over 150,000 shares of USD 0.001 each in the Company ("Ordinary Shares"), exercisable at a price of 137.5p per Ordinary Share. These options have a vesting period of four years, and expire ten years from the Date of Grant. Following this grant, Mr Schneider will have options over 200,000 Ordinary Shares.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGMRNVLGGZG
Date   Source Headline
26th Mar 20145:00 pmRNSIntention to raise £10 million
10th Mar 20147:01 amRNSMemorandum of Understanding with China Telecom
27th Jan 20147:00 amRNSCommercial Launch in China
20th Jan 20147:00 amRNSChange of Adviser
17th Jan 20147:00 amRNSAIM Rule 17 Disclosure Schedule Two (g) Update
6th Jan 20147:00 amRNSExercise of Employee Warrants for Shares
19th Nov 20137:00 amRNSOperational Update for Phorm China
19th Nov 20137:00 amRNSEquity Placing to raise £10 million
13th Nov 20137:12 amRNSStmnt re Share Price Movement
24th Oct 201311:16 amRNSOperations Update
3rd Oct 20137:00 amRNSOperational Launch in China
30th Sep 20137:00 amRNSInterim Results
27th Sep 20137:00 amRNSOperations Update
28th Aug 201312:43 pmRNSAGM Statement
7th Aug 201310:52 amRNSStmnt re Share Price Movement
6th Aug 20137:00 amRNSAGM Statement
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
17th Jul 20139:20 amRNSIssue of Equity
28th Jun 20137:20 amRNSAnnual Report and Financial Statements
28th Jun 20137:20 amRNSTurkish Operations Update
29th May 20137:00 amRNSFinancing Update
8th May 20138:34 amRNSHolding(s) in Company
23rd Apr 201310:18 amRNSPlacing to raise £7.15 million
21st Mar 20133:20 pmRNSStatement re Share Price Movement
20th Mar 20137:00 amRNSFinancing Update
24th Jan 20137:00 amRNSChinese and Turkish Operations Update
4th Jan 20137:00 amRNSIssue of Shares
18th Dec 20127:00 amRNSIssue of Shares
17th Dec 20127:00 amRNSTurkish Operational Update
13th Dec 20127:00 amRNSTR1: Notification of major interest in shares
21st Nov 201212:33 pmRNSResult of EGM & Admission to trading
6th Nov 201211:50 amRNS£6m Placing, Contract Signature & Turkey Update
16th Oct 20127:00 amRNSCommercial Progress Update
28th Sep 20127:00 amRNSInterim Results
20th Sep 20127:00 amRNSUpdate on Turkey and Phorm China Equity Fundraise
11th Sep 20127:00 amRNSAdmission to Trading
10th Sep 20123:33 pmRNSSch 1 Update - Phorm Corporation Limited
7th Sep 20122:58 pmRNSResults of EGM - Correction
7th Sep 201212:29 pmRNSResults of EGM
5th Sep 20124:15 pmRNSNotification of Major Interests in Shares
31st Aug 20123:49 pmRNSUpdated Appendix to Schedule 1
13th Aug 20129:06 amRNSSchedule 1 - Phorm Corporation Limited
13th Aug 20127:00 amRNSPhorm Re-Domicile of Holding Company from Delaware
2nd Aug 20127:00 amRNSPlacing
9th Jul 20127:00 amRNSCommencement of Commercial Activities with TTNET
3rd Jul 201210:14 amRNSTransfer of Shares
29th Jun 20127:00 amRNSAnnual Financial Report
19th Jun 20126:01 pmRNSCorrection: AGM Result
19th Jun 201211:29 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.